Recombinant Proteins Market Worth $2.4 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In 2022, Twist Bioscience Corporation (US) signed a licensing agreement under which Abcam plc (UK) to use a proprietary Twist VHH phage library for the antibody discovery, development, and commercialization of diagnostic and research applications.
View full press release